Introduction
Aerogen specializes in high-performance aerosol drug delivery systems, utilizing unique vibrating mesh technology to enhance medication delivery to the lungs. This document outlines the specifications, performance, and benefits of Aerogen's devices, particularly the Aerogen Solo and Aerogen Ultra.

Specifications and Technology
The core of Aerogen's devices is the palladium vibrating mesh technology, featuring a dome-shaped aperture plate with over 1,000 precision-formed holes. This technology vibrates at 128,000 times per second, creating a fine mist of droplets sized 1-5μm, which ensures superior lung deposition.

Performance and Efficacy
Aerogen devices are designed for both ventilated and non-ventilated patients, offering superior drug delivery compared to traditional jet nebulisers. The Aerogen Solo delivers a 3X greater lung dose during non-invasive ventilation (NIV) and achieves higher drug doses across all patient populations. It provides better lung deposition at lower flow rates, with significant improvements noted at 30L/min.

Clinical Benefits
Aerogen devices ensure confidence and control in patient care by delivering the prescribed dose with minimal residual volume. They are virtually silent, easy to set up, and do not affect ventilator parameters. The devices are suitable for a wide range of medications, including solutions, suspensions, proteins, and peptides, without heating or degrading the medication.

Comparative Studies
Studies show that Aerogen devices outperform jet nebulisers in drug delivery efficiency. For example, the Aerogen Solo achieves a deposition rate of 5.5% compared to 1.5% with jet nebulisers. The Aerogen Ultra delivers a 6X greater lung dose for spontaneous breathing patients, leading to improved patient responses.

Conclusion
Aerogen's innovative technology and design provide significant advantages in aerosol drug delivery, ensuring effective and efficient treatment for patients across various modalities.